BiochemistrybioRxiv
Biparatopic sybody constructs neutralize SARS-CoV-2 variants of concern and mitigate emergence of drug resistance
DOI 10.15252/embr.202154199
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
2 papers
Recent·Most cited
R.-A. A. Garibsingh, E. Ndaru, A. A. Garaeva…·A. Schlessinger
The paper rationally designs inhibitors for ASCT2 using computational modeling and cryo-EM, showing how stereospecific pockets can be exploited for drug discovery.